The research landscape of ferroptosis in neurodegenerative disease: a bibliometric analysis.

Yun Liu, Dan Feng, Ling Shui, Yu-Jie Wang, Li Yu, Yu-Qi Liu, Jin-Yong Tian
Author Information
  1. Yun Liu: First Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
  2. Dan Feng: First Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
  3. Ling Shui: Department of General Practice, Guizhou Provincial People's Hospital, Guiyang, China.
  4. Yu-Jie Wang: First Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
  5. Li Yu: First Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
  6. Yu-Qi Liu: First Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
  7. Jin-Yong Tian: Department of General Practice, Guizhou Provincial People's Hospital, Guiyang, China.

Abstract

Background: Ferroptosis, a newly proposed concept of programmed cell death, has garnered significant attention in research across different diseases in the last decade. Despite thorough citation analyses in neuroscience, there is a scarcity of information on ferroptosis research specifically related to neurodegenerative diseases.
Method: The Web of Science Core Collection database retrieved relevant articles and reviews. Data on publications, countries, institutions, authors, journals, citations, and keywords in the included studies were systematically analyzed using Microsoft Excel 2019 and CiteSpace 6.2.R7 software.
Result: A comprehensive analysis and visualization of 563 research papers on ferroptosis in neurodegenerative diseases from 2014 to 2023 revealed emerging research hotspots and trends. The number of annual publications in this field of study has displayed a pattern of stabilization in the early years of the decade, followed by a notable increase in the later years and peaking in 2023 with 196 publications. Regarding publication volume and total citations, notable research contributions were observed from countries, institutions, and authors in North America, Western Europe, and China. Current research endeavors primarily focus on understanding the intervention mechanisms of neurodegenerative diseases through the ferroptosis pathway and exploring and identifying potential therapeutic targets.
Conclusion: The study highlights key areas of interest and emerging trends in ferroptosis research on neurodegenerative diseases, offering valuable insights for further exploration and potential directions for diagnosing and treating such conditions.

Keywords

References

  1. Cell Death Differ. 2021 Jul;28(7):2029-2044 [PMID: 34099897]
  2. Front Cell Dev Biol. 2021 Nov 16;9:789517 [PMID: 34869391]
  3. Autophagy. 2023 Oct;19(10):2621-2638 [PMID: 37272058]
  4. Sci Transl Med. 2022 Apr 27;14(642):eabm5527 [PMID: 35476595]
  5. Front Mol Biosci. 2022 Aug 17;9:974156 [PMID: 36060242]
  6. Cell Death Differ. 2021 Oct;28(10):2843-2856 [PMID: 34465893]
  7. Curr Probl Cardiol. 2022 Dec;47(12):101361 [PMID: 35995242]
  8. Geriatr Orthop Surg Rehabil. 2020 Nov 11;11:2151459320973196 [PMID: 33240559]
  9. Front Med. 2023 Apr;17(2):173-206 [PMID: 37121959]
  10. Cell Death Discov. 2021 Jul 26;7(1):193 [PMID: 34312370]
  11. Theranostics. 2021 Jan 1;11(7):3052-3059 [PMID: 33537073]
  12. Cold Spring Harb Perspect Biol. 2017 Jul 5;9(7): [PMID: 28062563]
  13. Redox Biol. 2021 Oct 30;48:102175 [PMID: 34736120]
  14. Cell. 2018 Jan 25;172(3):409-422.e21 [PMID: 29290465]
  15. Redox Biol. 2016 Aug;8:323-32 [PMID: 26966891]
  16. Genes Dev. 2023 Mar 1;37(5-6):204-217 [PMID: 36921996]
  17. Biomed Res Int. 2020 Oct 05;2020:2580795 [PMID: 33083458]
  18. Int J Hyperthermia. 2022;39(1):664-674 [PMID: 35465811]
  19. AMIA Annu Symp Proc. 2005;:724-8 [PMID: 16779135]
  20. J Clin Invest. 2021 Nov 15;131(22): [PMID: 34609966]
  21. Autophagy. 2020 Aug;16(8):1482-1505 [PMID: 31679460]
  22. Pharmacol Res. 2021 Jul;169:105645 [PMID: 33957268]
  23. Nat Chem Biol. 2017 Jan;13(1):91-98 [PMID: 27842070]
  24. Ann Palliat Med. 2022 May;11(5):1700-1713 [PMID: 35016519]
  25. Eur J Pharmacol. 2024 Jun 15;973:176600 [PMID: 38643834]
  26. Biology (Basel). 2024 Mar 26;13(4): [PMID: 38666827]
  27. Pharmacol Res. 2021 Apr;166:105466 [PMID: 33548489]
  28. Nat Rev Cardiol. 2023 Jan;20(1):7-23 [PMID: 35788564]
  29. Cell Metab. 2023 Oct 3;35(10):1688-1703.e10 [PMID: 37793345]
  30. J Alzheimers Dis Rep. 2024 Jan 29;8(1):129-142 [PMID: 38312529]
  31. Cell Rep. 2021 Jun 15;35(11):109235 [PMID: 34133924]
  32. Int Immunopharmacol. 2021 Oct;99:108002 [PMID: 34333354]
  33. Brain Res. 2023 Aug 1;1812:148383 [PMID: 37149247]
  34. Nat Chem Biol. 2023 Jun;19(6):719-730 [PMID: 36747055]
  35. Genes Dis. 2020 Sep 29;9(2):334-346 [PMID: 35224150]
  36. Redox Biol. 2017 Aug;12:8-17 [PMID: 28212525]
  37. Pharmacol Res. 2020 Sep;159:104919 [PMID: 32464324]
  38. Exp Gerontol. 2024 Jul;192:112443 [PMID: 38697556]
  39. Int J Mol Sci. 2022 Oct 25;23(21): [PMID: 36361643]
  40. Nat Rev Mol Cell Biol. 2021 Apr;22(4):266-282 [PMID: 33495651]
  41. Front Cell Neurosci. 2020 Aug 06;14:231 [PMID: 32848622]
  42. Methods Mol Biol. 2020;2108:125-130 [PMID: 31939176]
  43. Pharmacol Ther. 2023 Apr;244:108373 [PMID: 36894028]
  44. Sci Adv. 2022 Jul 8;8(27):eabl8809 [PMID: 35857446]
  45. Free Radic Res. 2023 Apr;57(4):282-293 [PMID: 37401821]
  46. Stem Cell Reports. 2019 Nov 12;13(5):832-846 [PMID: 31587993]
  47. Mol Biol Rep. 2023 Feb;50(2):1655-1661 [PMID: 36385663]
  48. Br J Pharmacol. 2019 Sep;176(18):3622-3635 [PMID: 30632143]
  49. J Inflamm Res. 2021 May 20;14:2079-2090 [PMID: 34045882]
  50. Neuroimage. 2019 Feb 15;187:209-225 [PMID: 29793062]
  51. Cell Death Differ. 2016 Mar;23(3):369-79 [PMID: 26794443]
  52. PLoS One. 2019 Oct 31;14(10):e0223994 [PMID: 31671124]
  53. Front Oncol. 2023 Jan 13;13:1099731 [PMID: 36712497]
  54. Mol Metab. 2022 Jul;61:101502 [PMID: 35447365]
  55. Antioxid Redox Signal. 2022 Apr 8;: [PMID: 35243895]
  56. Proc Natl Acad Sci U S A. 2004 Apr 6;101 Suppl 1:5303-10 [PMID: 14724295]
  57. Brain Res Bull. 2020 Mar;156:15-24 [PMID: 31843561]
  58. Exp Mol Med. 2022 Feb;54(2):91-102 [PMID: 35217834]
  59. Cell. 2017 Oct 5;171(2):273-285 [PMID: 28985560]
  60. Cell Death Dis. 2019 Oct 28;10(11):822 [PMID: 31659150]
  61. Mol Neurobiol. 2018 Jul;55(7):5767-5786 [PMID: 29052145]
  62. Drug Des Devel Ther. 2024 Apr 03;18:1053-1081 [PMID: 38585257]
  63. Nat Chem Biol. 2017 Jan;13(1):81-90 [PMID: 27842066]
  64. Nat Rev Mol Cell Biol. 2020 Feb;21(2):85-100 [PMID: 31636403]
  65. Redox Biol. 2021 Jan;38:101789 [PMID: 33212416]
  66. Adv Sci (Weinh). 2023 Aug;10(24):e2300325 [PMID: 37341302]
  67. Curr Cancer Drug Targets. 2022;22(3):234-244 [PMID: 35152865]
  68. Cell Death Dis. 2023 Jul 13;14(7):426 [PMID: 37443140]
  69. Cells. 2020 Jun 20;9(6): [PMID: 32575749]
  70. Nature. 2019 Nov;575(7784):688-692 [PMID: 31634900]
  71. Chin Med. 2022 Jul 4;17(1):82 [PMID: 35787281]
  72. J Cell Physiol. 2020 Apr;235(4):3329-3339 [PMID: 31541463]
  73. Cell Death Differ. 2023 Feb;30(2):304-312 [PMID: 36447047]
  74. Neurosci Lett. 2021 Mar 16;747:135614 [PMID: 33485988]
  75. Cell Stem Cell. 2023 May 4;30(5):512-529 [PMID: 37084729]
  76. Redox Biol. 2022 Dec;58:102537 [PMID: 36436456]
  77. Heliyon. 2024 Apr 09;10(8):e29418 [PMID: 38638970]
  78. Cell Death Dis. 2020 Feb 3;11(2):88 [PMID: 32015325]
  79. Nat Neurosci. 2023 Jan;26(1):12-26 [PMID: 36536241]
  80. Int J Mol Sci. 2020 Nov 20;21(22): [PMID: 33233496]
  81. Cell Death Differ. 2018 Mar;25(3):486-541 [PMID: 29362479]
  82. Antioxidants (Basel). 2022 Feb 16;11(2): [PMID: 35204286]
  83. Cell. 2022 Jul 7;185(14):2401-2421 [PMID: 35803244]
  84. Front Aging Neurosci. 2023 Nov 14;15:1278323 [PMID: 38035275]
  85. RSC Adv. 2023 Nov 2;13(46):32276-32281 [PMID: 37928844]
  86. Nat Immunol. 2021 Sep;22(9):1107-1117 [PMID: 34385713]
  87. Signal Transduct Target Ther. 2023 Dec 10;8(1):449 [PMID: 38072908]

Word Cloud

Created with Highcharts 10.0.0researchdiseasesferroptosisneurodegenerativepublicationsanalysisdecadecountriesinstitutionsauthorscitationsCiteSpace2023emerginghotspotstrendsstudyyearsnotablepotentialbibliometricBackground:FerroptosisnewlyproposedconceptprogrammedcelldeathgarneredsignificantattentionacrossdifferentlastDespitethoroughcitationanalysesneurosciencescarcityinformationspecificallyrelatedMethod:WebScienceCoreCollectiondatabaseretrievedrelevantarticlesreviewsDatajournalskeywordsincludedstudiessystematicallyanalyzedusingMicrosoftExcel201962R7softwareResult:comprehensivevisualization563papers2014revealednumberannualfielddisplayedpatternstabilizationearlyfollowedincreaselaterpeaking196RegardingpublicationvolumetotalcontributionsobservedNorthAmericaWesternEuropeChinaCurrentendeavorsprimarilyfocusunderstandinginterventionmechanismspathwayexploringidentifyingtherapeutictargetsConclusion:highlightskeyareasinterestofferingvaluableinsightsexplorationdirectionsdiagnosingtreatingconditionslandscapedisease:knowledgegraph

Similar Articles

Cited By

No available data.